Traumatic Optic Neuropathy Clinical Trial
Official title:
Targeted Shortwave Diathermy Combined With Perceptual Training for Patients With Severe Traumatic Optic Neuropathy After Endoscopic Optic Nerve Decompression: a Preliminary Clinical Trial.
Purpose: Patients with severe traumatic optic neuropathy (TON) have limited improvement in visual function despite therapy. The hypothesis of the study is that the targeted shortwave diathermy combined with perceptual training may enhance visual function in patients with severe TON after endoscopic optic nerve decompression (EOND) surgery. Design: Clinical trial Subjects: Twenty-two subjects with severe TON after EOND surgery were randomly assigned to either a rehabilitation (Reh) group or nonrehabilitation (Nreh) group. Methods: High-resolution computed tomography and MRI were used to locate the impaired nerve. The subjects in the Reh group received targeted shortwave diathermy therapy 5 days per week for 4 weeks and perceptual training 5 days per week for 10 weeks. Main Outcome Measures: A thorough evaluation of visual function, visual evoked potential, and diffusion tensor imaging was executed.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 60 Years |
Eligibility | Inclusion criteria: The indications for endoscopic optic nerve decompression surgery included no improvement after intravenous treatment for 24 hours, no evidence of injury in the intracranial portion of the optic nerve, and the presence of bony fragments or hematoma compressing the optic nerve. TON with best-corrected visual acuity equal to or more than 1.85 logMAR after surgery was considered as severe TON, and those patients managed with endoscopic optic nerve decompression surgery were recruited in this study. Eligible criteria for the participants were as follows: (1) not receiving other physical therapy regimens aside from this intervention; (2) age 3 to 60 years old; (3) ability to execute simple verbal instructions; (4) not being delirious; (5) having stable vital signs and medical conditions. Exclusion criteria: The exclusion criteria included severe diffuse brain damage, and/or severe cardiac and pulmonary disease, which were contraindicated in rehabilitation procedure. |
Country | Name | City | State |
---|---|---|---|
China | Tang | Changsha |
Lead Sponsor | Collaborator |
---|---|
Hunan Provincial People's Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MRI | A 32-channel head coil on a 3.0T MRI system (Philips, Ltd, Best, the Netherlands) was used for the acquisition of imaging data. T1- and T2-weighted, fat-suppressed images were obtained axially through the orbit and some parts of the brain, including the intracranial portion of the optic nerve, postoperatively and 10 weeks after rehabilitation. | 15 minutes | |
Primary | Diffusion tensor imaging | Optic nerve diffusion tensor imaging images were obtained using single-shot echoplanar imaging sequences. The images were acquired from the optic papilla to the orbital apex of the optic nerve with 40 contiguous slices. The region of interest was manually manually placed over the optic nerve at the anterior, middle, and posterior segments on the non-diffusion-weighted image. The fraction anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity of optic nerves were measured. | 15 minutes | |
Secondary | Visual evoked potential | Pattern visual evoked potential testing was recorded using an MEB-9404C (Nihon Kohden Corp, Tokyo, Japan). The latency and amplitude of the P100 wave in the VEP testing were collected for analysis. | 30 minutes | |
Secondary | Best-corrected visual acuity | Best-corrected visual acuity was measured by a standardized Snellen visual chart. Visual results were converted into logMAR units for the convenience of statistical analysis. Hand motion, light perception, and no light perception were converted to 2.3, 2.5, and 3 logMAR units, respectively. | 5 minutes | |
Secondary | Color vision | Color vision was evaluated using the Ishihara color vision test 24 plate. The exclusion criterion of the color vision test was congenital color vision deficiency. The number of correct answers in a set of 24 plates was recorded as the color vision score. | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06168188 -
The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy
|
Early Phase 1 | |
Completed |
NCT03308448 -
Traumatic Optic Neuropathy Treatment Trial 2
|
Phase 3 | |
Recruiting |
NCT02711982 -
Surgery for Traumatic Optic Neuropathy
|
N/A | |
Recruiting |
NCT05353413 -
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
|
N/A | |
Completed |
NCT01783847 -
Traumatic Optic Neuropathy Treatment Trial (TONTT)
|
Phase 1/Phase 2 | |
Recruiting |
NCT05147701 -
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases
|
Phase 1 |